Healthcare Sales & Marketing Network News: Prezeon

Searching News Database: Prezeon

HSMN NewsFeed - 13 Jun 2013
Supreme Court Upholds Myriad's cDNA Patent Claims
Diagnostics Oncology Litigation

HSMN NewsFeed - 5 Mar 2013
Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
Diagnostics Urology Oncology

HSMN NewsFeed - 9 Dec 2011
Myriad Genetics Presents BRACAnalysis(R) Cost-Effectiveness Study at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Diagnostics Oncology

HSMN NewsFeed - 20 Dec 2010
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Diagnostics Oncology

HSMN NewsFeed - 8 Dec 2010
Myriad Acquires Novel Technology From Melanoma Diagnostics
Diagnostics Oncology Acquisitions

HSMN NewsFeed - 26 Oct 2010
Myriad and Abbott Enter Into Cooperative Agreement
Diagnostics Oncology

HSMN NewsFeed - 2 Mar 2010
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
Diagnostics Oncology

HSMN NewsFeed - 24 Mar 2009
Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
Diagnostics Oncology

HSMN NewsFeed - 22 Dec 2008
Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status
Diagnostics Oncology

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.